Mr. Sai Rangarao is a senior biopharmaceutical commercial leader with two decades of experience launching and scaling therapeutic portfolios in neurology, oncology, immunology, and rare disease. He is currently Chief Commercial Officer at Pelthos Therapeutics and serves on the…

Michael J. Kamdar is a seasoned life science & healthcare executive with over 30 years of international leadership experience. He is an industry veteran that has done over $1B in business deals and raised more than $450M from venture…

Dr. Garret Hampton is a recognized leader in translational oncology, clinical genomics, and precision medicine with over three decades of experience integrating molecular biology, biomarker science, and advanced diagnostics. Most recently, he served as President of Clinical Next Generation…

Dr. Carl Goldfischer has 30 years of investment, and his background includes extensive public and private investment and transaction work, as well as clinical trial development knowledge. From 2000 until 2020 he was a partner and member of the…

Dr. Emily Chen is an accomplished academic and scientific leader with over 15 years of experience in translational research, biomarker discovery, and proteomics innovation. She currently works as a Business Consultant at ECI Lifescience Consulting, advising biotech companies on…

Dr. Bradley Gordon is a senior life science executive and entrepreneur with over 25 years of leadership experience spanning venture capital, corporate finance, business development, and biopharmaceutical operations. He is currently President and CEO of Katmai Pharmaceuticals, an academic…

Jen Turbiak Carroll is a senior communications and investor relations strategist with over two decades of experience elevating the visibility of leading life sciences and genomics companies. She most recently led communications and investor relations at Telesis Bio, where…

Dr. Webb is currently CEO of Synbal(www.synbal.com), Chairman of the Board at Agragene (www.agragene/com)and Adjunct Professor at The Scripps Research Institute (TSRI).  He was Chairman of the Board of Sorrento Therapeutics from 2012-2014and is also former chairman of the…